wndm medical, inc.

With our focus on improving patient outcomes with evidence-based healing solutions, Sanara MedTech Inc., formerly named WNDM Medical Inc., develops, markets and distributes biotechnology products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our primary products are sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech sells and distributes CellerateRX®/CRXα® Surgical Activated Collagen® Adjuvant and HemaQuell® Resorbable Bone Hemostat to the surgical market and BIAKŌS Antimicrobial Skin and Wound Cleanser, HYCOL Hydrolyzed Collagen, and PULSAR II Advanced Wound Irrigation System (AWI) to the wound care market.